NOD1 activates autophagy to aggravate hepatic ischemia‐reperfusion injury in mice. Issue 6 (15th January 2019)

• Record Type: Journal Article
• Authors: Xi, Jiri; Yan, Meiling; Li, Shipeng; Song, Hu; Liu, Lei; Shen, Zhongyang; Cai, Jin‐Zhen
• Is Part Of: Journal of cellular biochemistry. Volume 120:Issue 6(2019)
• Page Start: 10605
• Page End: 10612
• Publication Date: 2019-01-15
• Subjects: autophagy -- hepatic ischemia‐reperfusion injury -- NOD1; Cytochemistry -- Periodicals; 572
• DOI: 10.1002/jcb.28349
• Languages: English
• ISSNs: 0730-2312

Abstract

Abstract: Hepatic ischemia/reperfusion injury (IRI) is tissue damage resulting from return of the blood supply to the tissue after a period of ischemia or lack of oxygen. Much of the morbidity associated with liver transplantation and major hepatic resections is, in part, due to IRI. Both innate immunity and autophagy play important roles in hepatic IRI. With regard to innate immunity, one factor that plays a key role is NOD1, an intracellular pattern recognition receptor. NOD1 has recently been shown to be associated with autophagy, but the mechanisms involved with this process remain obscure. This relationship between NOD1 and autophagy prompted us to examine the role and potential mechanisms of NOD1 in regulating autophagy as related to hepatic IRI. We found that NOD1 was upregulated during hepatic IRI and was associated with an activation of the autophagic signaling pathway. Moreover, levels of Atg5, a critical protein associated with autophagy, were decreased when NOD1 was inhibited by NOD1 small interfering RNA. We conclude that NOD1 appears to exert a pivotal role in hepatic IRI by activating autophagy to aggravate hepatic IRI, and Atg5 was required for this process. The identification of this novel pathway, that links expression levels of NOD1 with Atg5‐mediated autophagy, may provide new insights for the generation of novel protective therapies directed against hepatic IRI. Abstract : NOD1 appeared to exert a pivotal role in hepatic ischemia/reperfusion injury (IRI), by activating autophagy to aggravated hepatic IRI, and Atg5 was required for this process. The identification of this novel pathway, that links expression levels of nod1 with Atg5‐mediated autophagy, may provide new insights for the generation of novel protective therapies directed against hepatic IRI.